Dr. Azza Ibrahim participated in the European Congress on Obesity 2026 (ECO 2026) in Istanbul, Türkiye, following an invitation from MPC, as part of her ongoing commitment to staying up to date with the latest scientific developments in obesity treatment and metabolic health.
The European Congress on Obesity is one of the leading scientific meetings dedicated to obesity research, prevention and management, bringing together physicians, researchers and healthcare professionals to discuss the latest evidence and advances in obesity care.
Latest Advances in Obesity Treatment and GLP-1 Therapies
During ECO 2026, Dr. Azza Ibrahim explored the latest research and developments in GLP-1 therapies, obesity treatment, weight management and metabolic health.
Modern approaches increasingly recognize obesity as a complex chronic disease requiring comprehensive assessment and individualized treatment strategies that focus not only on weight reduction, but also on improving metabolic health and managing obesity-related complications.
A Healthy Lifestyle as Part of Obesity Management
Dr. Azza Ibrahim also highlighted the importance of combining medical treatment with a healthy and active lifestyle.
Regular physical activity, including walking after meals, cycling and increasing daily movement, can support cardiovascular fitness, physical activity levels and overall metabolic health.
Dr. Azza Ibrahim’s participation in ECO 2026 reflects her continued commitment to medical education and evidence-based practice, enabling her to follow the latest global developments in obesity treatment, weight management, GLP-1 therapies and metabolic health and incorporate them into personalized treatment strategies.
